Brazil refuses permission to import Covaxin, Bharat Biotech says it will fulfil requirements© timesofindia.indiatimes.com

Brazil refuses permission to import Covaxin, Bharat Biotech says it will fulfil requirements

, 7 news, a view

Brazil’s health regulator has refused permission to import Bharat Biotech’s coronavirus vaccine Covaxin after its officials found that the plant where the shots were being made did not meet its manufacturing standards, PTI reported on Wednesday.

Anvisa, Brazil’s National Health Surveillance Agency, said it had received the government’s request to import 20 million (2 crore) doses of Covaxin. The decision on this request was suspended because of “non-compliance with the requirements of Good Manufacturing Practices for Medicines”, the news agency reported, citing a gazette notification from the Brazil government on March 29.

Bharat Biotech, in response to the development, told NDTV: “The requirements pointed out during inspection will be fulfilled, the timelines for fulfilment is under discussion with the Brazil NRA and will be resolved soon.’’